Trial Profile
Repeated Administration Of Recurrent Cycles of Rasburicase In Patients With Leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2014
Price :
$35
*
At a glance
- Drugs Rasburicase (Primary)
- Indications Hyperuricaemia; Tumour lysis syndrome
- Focus Adverse reactions; Therapeutic Use
- 12 May 2014 New trial record